Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover
Niagen Bioscience, Inc. (NAGE) had Days Sales in Receivables of 27.93 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$31.12M |
|
$3.61M |
|
$10.89M |
|
$20.23M |
|
$27.93M |
|
$3.19M |
|
$0.55M |
|
$3.74M |
|
$3.74M |
|
$3.61M |
|
$3.61M |
|
$3.61M |
|
$3.61M |
|
$3.19M |
|
$3.38M |
|
79.25M |
|
86.24M |
|
$0.05 |
|
$0.04 |
|
| Balance Sheet Financials | |
$86.68M |
|
$1.63M |
|
$4.85M |
|
$91.53M |
|
$22.33M |
|
-- |
|
$5.00M |
|
$27.33M |
|
$64.19M |
|
$63.91M |
|
$64.19M |
|
79.59M |
|
| Cash Flow Statement Financials | |
$9.13M |
|
$-0.17M |
|
$6.85M |
|
$44.66M |
|
$60.47M |
|
$15.81M |
|
$2.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.88 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
65.00% |
|
10.24% |
|
10.24% |
|
-- |
|
12.01% |
|
11.60% |
|
$8.97M |
|
-- |
|
-- |
|
-- |
|
0.34 |
|
0.76 |
|
3.22 |
|
|
Days Sales in Receivables |
27.93 |
5.62% |
|
5.65% |
|
3.94% |
|
5.62% |
|
$0.81 |
|
$0.10 |
|
$0.11 |
|